INTERNATIONAL ADTKD SUMMIT - WHAT'S NEW?
Study program expected
12/28/2022 - In October 2022 the 3rd International Virtual ADTKD Summit took place. The two-day meeting enables scientists and patients from all over the world to exchange information on the latest findings on ADTKD. Another important topic was the study activities with a potentially effective substance for the ADTKD subforms MUC1 and UMOD. The webinar was organized by the Rare Kidney Disease Foundation (RKDF) and the Broad Institute and was held in English.
On Day 1, researchers reported on current projects on ADTKD (2:06:14-2:17:29). We highly recommend to check out Katie Reed's story (4:57-00:36:38).
Video recording DAY 1:
Day 2 was dedicated to patient initiatives and the planned study program with the active ingredient BRD4780. This is scheduled to start in 2023. The round table (1:16:48-02:28:58) provided initial insights.
Video recording DAY 2:
